"""RGLS"""

Regulus Therapeutics Inc.CIK 1505512 ☆ Sign in to watch Congress trades

Open-mkt buys · 90d

—

0 trades · 0 insiders

Open-mkt sales · 90d

—

0 trades · 0 insiders

Net · 90d

Insiders on file

AI insights for """RGLS""" PRO

XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%

AI insights for """RGLS"""

Insider sentiment score with a plain-English explanation, conviction score on every buy, and how the stock performed 30 and 90 days after past insider buys.

Upgrade to Pro · $99/year Already Pro? Log in

Daily buy vs sell · 90 days

No data yet.

Insiders

Insider	Role	Trades	Bought	Sold	Last trade
ISIS PHARMACEUTICALS INC	Director, 10% Owner	20	$0	$338.3K	2014-08-29
ALNYLAM PHARMACEUTICALS, INC.	10% Owner	29	$0	$507.7K	2014-08-29
XANTHOPOULOS KLEANTHIS G	President & CEO	30	$0	$223.3K	2014-08-28
PARSHALL B LYNNE	Director, 10% Owner	9	$0	$169.4K	2014-08-22
Gibson Neil W	Chief Scientific Officer	20	$0	$255.8K	2014-07-01
GRINT PAUL C	Chief Medical Officer	1	$0	$0	2014-06-16
FOLETTA MARK G	Director	1	$0	$0	2014-05-22
CARTER BRUCE L A	Director	1	$0	$0	2014-05-22
RASTETTER WILLIAM H	Director	1	$0	$0	2014-05-22
PAPADOPOULOS STELIOS	Director	1	$0	$0	2014-05-22
BALTIMORE DAVID	Director	2	$0	$0	2014-05-22
WILLIAMS DOUGLAS E	Director	1	$0	$0	2014-05-22

Trade history

Insider	Role	Code	Trade	Filed	Shares	Price	Value	Owned after
ALNYLAM PHARMACEUTICALS, INC.	10% Owner	S Sale	2014-08-29	2014-08-29	1,500	$6.84	$10.3K	6,077,650	SEC↗
ISIS PHARMACEUTICALS INC	Director, 10% Owner	S Sale	2014-08-29	2014-08-29	1,500	$6.84	$10.3K	6,976,650	SEC↗
XANTHOPOULOS KLEANTHIS G	President & CEO	M Exercise deriv	2014-08-28	2014-08-29	3,505	—	$0	455,297	SEC↗
XANTHOPOULOS KLEANTHIS G	President & CEO	M Exercise	2014-08-28	2014-08-29	3,505	$0.38	$1.3K	3,505	SEC↗
XANTHOPOULOS KLEANTHIS G	President & CEO	S Sale	2014-08-28	2014-08-29	3,505	$7.06	$24.7K	0	SEC↗
ALNYLAM PHARMACEUTICALS, INC.	10% Owner	S Sale	2014-08-28	2014-08-29	2,000	$6.96	$13.9K	6,079,150	SEC↗
ISIS PHARMACEUTICALS INC	Director, 10% Owner	S Sale	2014-08-28	2014-08-29	2,000	$6.96	$13.9K	6,978,150	SEC↗
ALNYLAM PHARMACEUTICALS, INC.	10% Owner	S Sale	2014-08-27	2014-08-29	1,500	$7.21	$10.8K	6,081,150	SEC↗
ISIS PHARMACEUTICALS INC	Director, 10% Owner	S Sale	2014-08-27	2014-08-29	1,500	$7.21	$10.8K	6,980,150	SEC↗
PARSHALL B LYNNE	Director, 10% Owner	S Sale	2014-08-22	2014-08-22	5,250	$6.75	$35.4K	6,981,650	SEC↗
ALNYLAM PHARMACEUTICALS, INC.	10% Owner	S Sale	2014-08-22	2014-08-22	5,250	$6.75	$35.4K	6,082,650	SEC↗
PARSHALL B LYNNE	Director, 10% Owner	S Sale	2014-08-21	2014-08-22	2,500	$6.89	$17.2K	6,986,900	SEC↗
ALNYLAM PHARMACEUTICALS, INC.	10% Owner	S Sale	2014-08-21	2014-08-22	2,500	$6.89	$17.2K	6,087,900	SEC↗
PARSHALL B LYNNE	Director, 10% Owner	S Sale	2014-08-20	2014-08-22	3,000	$7.14	$21.4K	6,989,400	SEC↗
ALNYLAM PHARMACEUTICALS, INC.	10% Owner	S Sale	2014-08-20	2014-08-22	3,000	$7.14	$21.4K	6,090,400	SEC↗
ISIS PHARMACEUTICALS INC	Director, 10% Owner	S Sale	2014-08-15	2014-08-15	1,450	$6.98	$10.1K	6,992,400	SEC↗
ALNYLAM PHARMACEUTICALS, INC.	10% Owner	S Sale	2014-08-15	2014-08-15	1,450	$6.98	$10.1K	6,093,400	SEC↗
ISIS PHARMACEUTICALS INC	Director, 10% Owner	S Sale	2014-08-14	2014-08-15	1,750	$7.04	$12.3K	6,993,850	SEC↗
ALNYLAM PHARMACEUTICALS, INC.	10% Owner	S Sale	2014-08-14	2014-08-15	1,750	$7.04	$12.3K	6,094,850	SEC↗
ISIS PHARMACEUTICALS INC	Director, 10% Owner	S Sale	2014-08-13	2014-08-15	2,250	$7.02	$15.8K	6,995,600	SEC↗
ALNYLAM PHARMACEUTICALS, INC.	10% Owner	S Sale	2014-08-13	2014-08-15	2,250	$7.02	$15.8K	6,096,600	SEC↗
ALNYLAM PHARMACEUTICALS, INC.	10% Owner	S Sale	2014-08-08	2014-08-08	1,850	$6.80	$12.6K	6,098,850	SEC↗
ISIS PHARMACEUTICALS INC	Director, 10% Owner	S Sale	2014-08-08	2014-08-08	1,850	$6.80	$12.6K	6,997,850	SEC↗
ALNYLAM PHARMACEUTICALS, INC.	10% Owner	S Sale	2014-08-07	2014-08-08	2,600	$6.66	$17.3K	6,100,700	SEC↗
ISIS PHARMACEUTICALS INC	Director, 10% Owner	S Sale	2014-08-07	2014-08-08	2,600	$6.66	$17.3K	6,999,700	SEC↗
ALNYLAM PHARMACEUTICALS, INC.	10% Owner	S Sale	2014-08-06	2014-08-08	3,150	$7.08	$22.3K	6,103,300	SEC↗
ISIS PHARMACEUTICALS INC	Director, 10% Owner	S Sale	2014-08-06	2014-08-08	3,150	$7.08	$22.3K	7,002,300	SEC↗
XANTHOPOULOS KLEANTHIS G	President & CEO	M Exercise deriv	2014-08-05	2014-08-07	3,505	—	$0	458,802	SEC↗
XANTHOPOULOS KLEANTHIS G	President & CEO	S Sale	2014-08-05	2014-08-07	3,505	$7.06	$24.7K	0	SEC↗
XANTHOPOULOS KLEANTHIS G	President & CEO	M Exercise	2014-08-05	2014-08-07	3,505	$0.38	$1.3K	3,505	SEC↗
ISIS PHARMACEUTICALS INC	Director, 10% Owner	S Sale	2014-08-01	2014-08-01	2,600	$6.21	$16.1K	7,005,450	SEC↗
ALNYLAM PHARMACEUTICALS, INC.	10% Owner	S Sale	2014-08-01	2014-08-01	2,600	$6.21	$16.1K	6,106,450	SEC↗
ISIS PHARMACEUTICALS INC	Director, 10% Owner	S Sale	2014-07-31	2014-08-01	1,750	$6.42	$11.2K	7,008,050	SEC↗
ALNYLAM PHARMACEUTICALS, INC.	10% Owner	S Sale	2014-07-31	2014-08-01	1,750	$6.42	$11.2K	6,109,050	SEC↗
ISIS PHARMACEUTICALS INC	Director, 10% Owner	S Sale	2014-07-30	2014-08-01	1,000	$6.60	$6.6K	7,009,800	SEC↗
ALNYLAM PHARMACEUTICALS, INC.	10% Owner	S Sale	2014-07-30	2014-08-01	1,000	$6.60	$6.6K	6,110,800	SEC↗
ALNYLAM PHARMACEUTICALS, INC.	10% Owner	S Sale	2014-07-25	2014-07-25	1,700	$6.55	$11.1K	6,111,800	SEC↗
PARSHALL B LYNNE	Director, 10% Owner	S Sale	2014-07-25	2014-07-25	1,700	$6.55	$11.1K	7,010,800	SEC↗
ALNYLAM PHARMACEUTICALS, INC.	10% Owner	S Sale	2014-07-24	2014-07-25	1,850	$6.81	$12.6K	6,113,500	SEC↗
PARSHALL B LYNNE	Director, 10% Owner	S Sale	2014-07-24	2014-07-25	1,850	$6.81	$12.6K	7,012,500	SEC↗
ALNYLAM PHARMACEUTICALS, INC.	10% Owner	S Sale	2014-07-23	2014-07-25	1,700	$6.88	$11.7K	6,115,350	SEC↗
PARSHALL B LYNNE	Director, 10% Owner	S Sale	2014-07-23	2014-07-25	1,700	$6.88	$11.7K	7,014,350	SEC↗
ALNYLAM PHARMACEUTICALS, INC.	10% Owner	S Sale	2014-07-18	2014-07-18	5,000	$6.80	$34.0K	6,117,050	SEC↗
ISIS PHARMACEUTICALS INC	Director, 10% Owner	S Sale	2014-07-18	2014-07-18	5,000	$6.80	$34.0K	7,016,050	SEC↗
ALNYLAM PHARMACEUTICALS, INC.	10% Owner	S Sale	2014-07-17	2014-07-18	5,000	$6.58	$32.9K	6,122,050	SEC↗
ISIS PHARMACEUTICALS INC	Director, 10% Owner	S Sale	2014-07-17	2014-07-18	5,000	$6.58	$32.9K	7,021,050	SEC↗
ALNYLAM PHARMACEUTICALS, INC.	10% Owner	S Sale	2014-07-16	2014-07-18	3,500	$6.59	$23.1K	6,127,050	SEC↗
ISIS PHARMACEUTICALS INC	Director, 10% Owner	S Sale	2014-07-16	2014-07-18	3,500	$6.59	$23.1K	7,026,050	SEC↗
ALNYLAM PHARMACEUTICALS, INC.	10% Owner	S Sale	2014-07-11	2014-07-11	1,750	$6.48	$11.3K	6,130,550	SEC↗
ISIS PHARMACEUTICALS INC	Director, 10% Owner	S Sale	2014-07-11	2014-07-11	1,750	$6.48	$11.3K	7,029,550	SEC↗
ALNYLAM PHARMACEUTICALS, INC.	10% Owner	S Sale	2014-07-10	2014-07-11	4,500	$6.69	$30.1K	6,132,300	SEC↗
ISIS PHARMACEUTICALS INC	Director, 10% Owner	S Sale	2014-07-10	2014-07-11	4,500	$6.69	$30.1K	7,031,300	SEC↗
ALNYLAM PHARMACEUTICALS, INC.	10% Owner	S Sale	2014-07-09	2014-07-11	1,800	$7.08	$12.7K	6,136,800	SEC↗
ISIS PHARMACEUTICALS INC	Director, 10% Owner	S Sale	2014-07-09	2014-07-11	1,800	$7.08	$12.7K	7,035,800	SEC↗
ISIS PHARMACEUTICALS INC	10% Owner	S Sale	2014-07-03	2014-07-07	1,200	$8.07	$9.7K	7,037,600	SEC↗
ALNYLAM PHARMACEUTICALS, INC.	10% Owner	S Sale	2014-07-03	2014-07-07	1,200	$8.07	$9.7K	6,138,600	SEC↗
ISIS PHARMACEUTICALS INC	10% Owner	S Sale	2014-07-02	2014-07-07	3,100	$8.07	$25.0K	7,038,800	SEC↗
ALNYLAM PHARMACEUTICALS, INC.	10% Owner	S Sale	2014-07-02	2014-07-07	3,100	$8.07	$25.0K	6,139,800	SEC↗
XANTHOPOULOS KLEANTHIS G	President & CEO	M Exercise deriv	2014-07-01	2014-07-02	3,505	—	$0	462,307	SEC↗
Gibson Neil W	Chief Scientific Officer	M Exercise deriv	2014-07-01	2014-07-02	2,500	—	$0	124,000	SEC↗
XANTHOPOULOS KLEANTHIS G	President & CEO	M Exercise	2014-07-01	2014-07-02	3,505	$0.38	$1.3K	3,505	SEC↗
XANTHOPOULOS KLEANTHIS G	President & CEO	S Sale	2014-07-01	2014-07-02	3,505	$8.11	$28.4K	0	SEC↗
Gibson Neil W	Chief Scientific Officer	S Sale	2014-07-01	2014-07-02	2,500	$8.10	$20.3K	80,000	SEC↗
Gibson Neil W	Chief Scientific Officer	M Exercise	2014-07-01	2014-07-02	2,500	$1.74	$4.3K	82,500	SEC↗
ALNYLAM PHARMACEUTICALS, INC.	10% Owner	S Sale	2014-06-27	2014-06-27	3,150	$7.91	$24.9K	6,142,900	SEC↗
PARSHALL B LYNNE	Director, 10% Owner	S Sale	2014-06-27	2014-06-27	3,150	$7.91	$24.9K	7,041,900	SEC↗
ALNYLAM PHARMACEUTICALS, INC.	10% Owner	S Sale	2014-06-26	2014-06-27	1,700	$7.89	$13.4K	6,146,050	SEC↗
PARSHALL B LYNNE	Director, 10% Owner	S Sale	2014-06-26	2014-06-27	1,700	$7.89	$13.4K	7,045,050	SEC↗
ALNYLAM PHARMACEUTICALS, INC.	10% Owner	S Sale	2014-06-25	2014-06-27	2,750	$7.84	$21.6K	6,147,750	SEC↗
PARSHALL B LYNNE	Director, 10% Owner	S Sale	2014-06-25	2014-06-27	2,750	$7.84	$21.6K	7,046,750	SEC↗
Gibson Neil W	Chief Scientific Officer	M Exercise deriv	2014-06-17	2014-06-18	5,000	—	$0	126,500	SEC↗
Gibson Neil W	Chief Scientific Officer	S Sale	2014-06-17	2014-06-18	5,000	$8.05	$40.3K	80,000	SEC↗
Gibson Neil W	Chief Scientific Officer	M Exercise	2014-06-17	2014-06-18	5,000	$1.74	$8.7K	85,000	SEC↗
GRINT PAUL C	Chief Medical Officer	A Award deriv	2014-06-16	2014-06-18	250,000	—	$0	250,000	SEC↗
XANTHOPOULOS KLEANTHIS G	President & CEO	M Exercise deriv	2014-06-09	2014-06-09	3,505	—	$0	465,812	SEC↗
XANTHOPOULOS KLEANTHIS G	President & CEO	M Exercise	2014-06-09	2014-06-09	3,505	$0.38	$1.3K	3,505	SEC↗
XANTHOPOULOS KLEANTHIS G	President & CEO	S Sale	2014-06-09	2014-06-09	3,505	$7.14	$25.0K	0	SEC↗
XANTHOPOULOS KLEANTHIS G	President & CEO	M Exercise deriv	2014-05-29	2014-05-29	887	—	$0	469,317	SEC↗
XANTHOPOULOS KLEANTHIS G	President & CEO	S Sale	2014-05-29	2014-05-29	887	$7.00	$6.2K	0	SEC↗
XANTHOPOULOS KLEANTHIS G	President & CEO	M Exercise	2014-05-29	2014-05-29	887	$0.38	$337	887	SEC↗
XANTHOPOULOS KLEANTHIS G	President & CEO	M Exercise deriv	2014-05-28	2014-05-29	875	—	$0	470,204	SEC↗
XANTHOPOULOS KLEANTHIS G	President & CEO	S Sale	2014-05-28	2014-05-29	875	$7.00	$6.1K	0	SEC↗
XANTHOPOULOS KLEANTHIS G	President & CEO	M Exercise	2014-05-28	2014-05-29	875	$0.38	$333	875	SEC↗
XANTHOPOULOS KLEANTHIS G	President & CEO	M Exercise deriv	2014-05-27	2014-05-29	1,743	—	$0	471,079	SEC↗
XANTHOPOULOS KLEANTHIS G	President & CEO	S Sale	2014-05-27	2014-05-29	1,743	$7.00	$12.2K	0	SEC↗
XANTHOPOULOS KLEANTHIS G	President & CEO	M Exercise	2014-05-27	2014-05-29	1,743	$0.38	$662	1,743	SEC↗
CARTER BRUCE L A	Director	A Award deriv	2014-05-22	2014-05-22	17,500	—	$0	17,500	SEC↗
BALTIMORE DAVID	Director	A Award deriv	2014-05-22	2014-05-22	17,500	—	$0	17,500	SEC↗
BALTIMORE DAVID	Director	A Award deriv	2014-05-22	2014-05-22	5,000	—	$0	5,000	SEC↗
PAPADOPOULOS STELIOS	Director	A Award deriv	2014-05-22	2014-05-22	17,500	—	$0	17,500	SEC↗
FOLETTA MARK G	Director	A Award deriv	2014-05-22	2014-05-22	17,500	—	$0	17,500	SEC↗
RASTETTER WILLIAM H	Director	A Award deriv	2014-05-22	2014-05-22	17,500	—	$0	17,500	SEC↗
WILLIAMS DOUGLAS E	Director	A Award deriv	2014-05-22	2014-05-22	17,500	—	$0	17,500	SEC↗
Gibson Neil W	Chief Scientific Officer	M Exercise deriv	2014-04-09	2014-04-10	2,500	—	$0	42,591	SEC↗
Gibson Neil W	Chief Scientific Officer	M Exercise deriv	2014-04-09	2014-06-18	91	—	$0	0	SEC↗
Gibson Neil W	Chief Scientific Officer	M Exercise deriv	2014-04-09	2014-06-18	2,409	—	$0	131,500	SEC↗
Gibson Neil W	Chief Scientific Officer	S Sale	2014-04-09	2014-04-10	2,500	$8.11	$20.3K	80,000	SEC↗
Gibson Neil W	Chief Scientific Officer	M Exercise	2014-04-09	2014-04-10	2,500	$1.74	$4.3K	82,500	SEC↗
XANTHOPOULOS KLEANTHIS G	President & CEO	M Exercise deriv	2014-04-08	2014-04-09	3,505	—	$0	472,822	SEC↗
Gibson Neil W	Chief Scientific Officer	M Exercise deriv	2014-03-06	2014-06-18	2,500	—	$0	91	SEC↗
XANTHOPOULOS KLEANTHIS G	President & CEO	M Exercise	2014-03-06	2014-04-09	3,505	$0.38	$1.3K	83,721	SEC↗
XANTHOPOULOS KLEANTHIS G	President & CEO	S Sale	2014-03-06	2014-04-09	3,505	$7.60	$26.6K	80,216	SEC↗
Gibson Neil W	Chief Scientific Officer	M Exercise deriv	2014-03-06	2014-03-07	2,500	—	$0	45,091	SEC↗
XANTHOPOULOS KLEANTHIS G	President & CEO	M Exercise deriv	2014-03-06	2014-03-07	3,505	—	$0	476,327	SEC↗
Gibson Neil W	Chief Scientific Officer	S Sale	2014-03-06	2014-03-07	2,500	$11.37	$28.4K	80,000	SEC↗
Gibson Neil W	Chief Scientific Officer	M Exercise	2014-03-06	2014-03-07	2,500	$1.74	$4.3K	82,500	SEC↗
XANTHOPOULOS KLEANTHIS G	President & CEO	M Exercise	2014-03-06	2014-03-07	3,505	$0.38	$1.3K	83,721	SEC↗
XANTHOPOULOS KLEANTHIS G	President & CEO	S Sale	2014-03-06	2014-03-07	3,505	$11.35	$39.8K	80,216	SEC↗
Gibson Neil W	Chief Scientific Officer	M Exercise deriv	2014-02-06	2014-02-07	45,000	—	$0	2,591	SEC↗
Gibson Neil W	Chief Scientific Officer	M Exercise	2014-02-06	2014-02-07	45,000	$1.74	$78.3K	80,000	SEC↗
Gibson Neil W	Chief Scientific Officer	M Exercise deriv	2014-02-05	2014-02-07	2,500	—	$0	47,591	SEC↗
XANTHOPOULOS KLEANTHIS G	President & CEO	M Exercise deriv	2014-02-05	2014-02-07	3,505	—	$0	479,832	SEC↗
Gibson Neil W	Chief Scientific Officer	S Sale	2014-02-05	2014-02-07	17,500	$8.38	$146.7K	35,000	SEC↗
Gibson Neil W	Chief Scientific Officer	M Exercise	2014-02-05	2014-02-07	2,500	$1.74	$4.3K	52,500	SEC↗
XANTHOPOULOS KLEANTHIS G	President & CEO	M Exercise	2014-02-05	2014-02-07	3,505	$0.38	$1.3K	83,721	SEC↗
XANTHOPOULOS KLEANTHIS G	President & CEO	S Sale	2014-02-05	2014-02-07	3,505	$8.40	$29.4K	80,216	SEC↗